Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03600441
Title Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma (FORERUNNER)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Xynomic Pharmaceuticals, Inc.
Indications

follicular lymphoma

Therapies

Abexinostat

Age Groups: senior | adult
Covered Countries USA | FRA | ESP


No variant requirements are available.